Case Study #3
A 55-year-old patient with hemophilia was part of a pilot group testing an online tool designed to improve patient adherence through real-time tracking and pharmacy notifications. He was taking a long acting prophylactic medication 3x per week. The cost of this medication was $7,600/dose, $91,200/month or more than $1 million/year.
Through the information the patient entered on the app, the pharmacy could see that he was taking this long acting medication more frequently than should be necessary to keep his condition under control. A treatment recommendation was made to switch to short acting therapy. The cost of this new medication was $2,850/dose, $34,200/month or $410,400/year.
- Changing the patient to the appropriate therapy saved the payer $684,000/year
- The health platform used by this patient helped to ensure that the he was on the right dose, at the right frequency, leading to cost savings for the payer